Ingevity Corp - 8-K Filing

Ingevity Corp reports Q3 2026 net sales of $305.1 million and narrows full-year adjusted EBITDA guidance to $385M-$395M. (Items: 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITIONOn November 4, 2026, Ingevity Corporation ("Ingevity") announced its preliminary financial resul, 9.01 FINANCIAL STATEMENTS AND EXHIBITS(d) Exhibits)

SEC EDGAR · November 4, 2026, 21:19 UTC

Tickers: $NGVT

Read the full article at SEC EDGAR

Part of the story KENNAMETAL INC - 8-K Filing (13 articles)

More Regulatory news

Bitwise Avalanche ETF - 8-K Filing SEC EDGAR · November 12, 2026, 15:06 UTC
MiNK Therapeutics, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:05 UTC
Future Vision II Acquisition Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:00 UTC
THUNDER MOUNTAIN GOLD INC - 10-Q Filing SEC EDGAR · November 12, 2026, 15:00 UTC
MiNK Therapeutics, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:49 UTC
SusGlobal Energy Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:42 UTC
Ideal Power Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:25 UTC
DIGI INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:23 UTC
ZeroStack Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 14:22 UTC
Sound Point Meridian Capital, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:22 UTC